Myloral: Began a two-year Phase III trial

AutoImmune Inc. (AIMM), Lexington, Mass. Product: Myloral, bovine myelin for oral tolerance therapy Indication: Relapsing-remitting multiple sclerosis Status: Began a two-year Phase III trial in the U...